GlycoPath
Charleston
About GlycoPath
GlycoPath develops software that analyses the glycosylation of various illnesses using MALDI mass spectrometry imaging. They provide assays to enhance patient care and treatment by creating simplified procedures with proven clinical impact. Their in-house-developed GlycoTyper is used to categories how proteins' glycans, or sugar codes, change as cancer spreads.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Grant (Mar 2022)
- Website: glycopath.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Medical
Canonical: https://fsome.com/organization/glycopath-2840426 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.